Future directions in cardiovascular disease risk prediction

Area of Science:

• Cardiovascular disease prevention
• Health informatics
• Medical decision making

Background:

• National Vascular Disease Prevention Alliance (NVDPA) guidelines for cardiovascular disease (CVD) risk were published in 2012.
• Many high-risk individuals are not prescribed preventive medication or have CVD risk factors unrecorded.
• Improved CVD risk assessment and medication targeting can reduce disease incidence.

Purpose of the Study:

• To review recent developments in cardiovascular disease (CVD) risk prediction.
• To examine calculators from the USA, UK, and New Zealand.
• To assess non-traditional tests for cardiovascular risk.

Main Methods:

• Review of recent cardiovascular disease (CVD) risk prediction tools.
• Evaluation of international risk calculators (USA, UK, New Zealand).
• Assessment of non-traditional cardiovascular risk assessment methods.

Main Results:

• The Framingham Risk Equation overestimates risk in contemporary Australian populations.
• Newer risk calculators demonstrate improved calibration.
• Shared decision-making tools aid in clarifying the perceived benefits of medication.

Conclusions:

• Current CVD risk prediction tools require refinement for contemporary populations.
• Enhanced risk assessment and shared decision-making can improve preventive strategies.
• Optimizing medication use based on accurate risk prediction is crucial for CVD reduction.